Tumor-specific ligand-like peptides, galactose-conjugated chitosan, transferrin, folic acid, and monoclonal antibodies have been employed to target microbubbles to tumor cells for the treatment of many cancers (Chertok et al., 2016; Chen et al., 2017; Tang et al., 2018). This evidence concerns the gene TF and neoplasm.